» Articles » PMID: 32211892

Heparan Sulfate is a Clearance Receptor for Aberrant Extracellular Proteins

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2020 Mar 27
PMID 32211892
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The accumulation of aberrant proteins leads to various neurodegenerative disorders. Mammalian cells contain several intracellular protein degradation systems, including autophagy and proteasomal systems, that selectively remove aberrant intracellular proteins. Although mammals contain not only intracellular but also extracellular proteins, the mechanism underlying the quality control of aberrant extracellular proteins is poorly understood. Here, using a novel quantitative fluorescence assay and genome-wide CRISPR screening, we identified the receptor-mediated degradation pathway by which misfolded extracellular proteins are selectively captured by the extracellular chaperone Clusterin and undergo endocytosis via the cell surface heparan sulfate (HS) receptor. Biochemical analyses revealed that positively charged residues on Clusterin electrostatically interact with negatively charged HS. Furthermore, the Clusterin-HS pathway facilitates the degradation of amyloid β peptide and diverse leaked cytosolic proteins in extracellular space. Our results identify a novel protein quality control system for preserving extracellular proteostasis and highlight its role in preventing diseases associated with aberrant extracellular proteins.

Citing Articles

Clusterin: structure, function and roles in disease.

Du X, Chen Z, Shui W Int J Med Sci. 2025; 22(4):887-896.

PMID: 39991767 PMC: 11843140. DOI: 10.7150/ijms.107159.


The secreted host-cell protein clusterin interacts with PmpD and promotes infection.

Kocher F, Hegemann J Front Cell Infect Microbiol. 2025; 14:1519883.

PMID: 39931630 PMC: 11807975. DOI: 10.3389/fcimb.2024.1519883.


Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.

Ye T, Jiang M, Zeng X, Zong D, Du Y, Li X Lupus Sci Med. 2023; 10(2).

PMID: 38154829 PMC: 10759090. DOI: 10.1136/lupus-2023-001051.


Clusterin is a Potential Therapeutic Target in Alzheimer's Disease.

Palihati N, Tang Y, Yin Y, Yu D, Liu G, Quan Z Mol Neurobiol. 2023; 61(7):3836-3850.

PMID: 38017342 DOI: 10.1007/s12035-023-03801-1.


Alpha 2-macroglobulin acts as a clearance factor in the lysosomal degradation of extracellular misfolded proteins.

Tomihari A, Kiyota M, Matsuura A, Itakura E Sci Rep. 2023; 13(1):4680.

PMID: 36977730 PMC: 10050189. DOI: 10.1038/s41598-023-31104-x.


References
1.
Snow A, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S . The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol. 1988; 133(3):456-63. PMC: 1880818. View

2.
Eckenroth B, Steere A, Chasteen N, Everse S, Mason A . How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH. Proc Natl Acad Sci U S A. 2011; 108(32):13089-94. PMC: 3156180. DOI: 10.1073/pnas.1105786108. View

3.
Shalem O, Sanjana N, Hartenian E, Shi X, Scott D, Mikkelson T . Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2013; 343(6166):84-87. PMC: 4089965. DOI: 10.1126/science.1247005. View

4.
Yerbury J, Stewart E, Wyatt A, Wilson M . Quality control of protein folding in extracellular space. EMBO Rep. 2005; 6(12):1131-6. PMC: 1369217. DOI: 10.1038/sj.embor.7400586. View

5.
Wojtas A, Kang S, Olley B, Gatherer M, Shinohara M, Lozano P . Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci U S A. 2017; 114(33):E6962-E6971. PMC: 5565413. DOI: 10.1073/pnas.1701137114. View